A 29-Year-Old Man Presents With Stage IV, Poorly Differentiated Malignant Melanoma
A 29-year-old man was presented early in this series as an example of stage IV, poorly differentiated malignant melanoma. As noted previously, evaluation disclosed the presence of multifocal metastatic disease (lungs, lymph nodes).
Aside from palliative resection of the bulky tumor mass, what newly approved drug might now be considered as a therapeutic option for this otherwise young, healthy individual?
